Clinical characteristics and outcomes of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis managed with different cytoreductive methods.
Georgios E ChristakopoulosKendra N WalkerJesse SmithClifford M TakemotoYan ZhengChing-Hong PuiRaul C RibeiroLei WangStanley B PoundsJeffrey E RubnitzHiroto InabaPublished in: Cancer (2023)
LD-cytarabine treatment appears to be a safe and effective means of cytoreduction for children with AML and hyperleukocytosis.